Satellos Bioscience
$8.97
8
-$0.11-1.21% Friday 20:00
+$0.14+1.56%Friday 23:30After hours
Statistics
Day High
9
Day Low
9
52W High
13.4
52W Low
5.3
Volume
525
Avg. Volume
-
Mkt Cap
190.31M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
25NovExpected
Q3 2025
Q1 2026
Q2 2026
Next
-0.59
-0.51
-0.42
-0.33
Expected EPS
-0.5944641549
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-19.87MNet Income
Analyst Ratings
20.33Average Price Target
The highest estimate is 23.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
Show more...
CEO
Frank Gleeson
Employees
21
Country
Canada
ISIN
CA80401L8033
WKN
000A4211W
Listings
0 Comments
Share your thoughts
FAQ
What is Satellos Bioscience stock price today?▼
The current price of MSLE is $8.97 USD — it has decreased by -1.21% in the past 24 hours. Watch Satellos Bioscience stock price performance more closely on the chart.
What is Satellos Bioscience stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Satellos Bioscience stocks are traded under the ticker MSLE.
What is Satellos Bioscience market cap?▼
Today Satellos Bioscience has the market capitalization of 190.31M
When is the next Satellos Bioscience earnings date?▼
Satellos Bioscience is going to release the next earnings report on November 25, 2026.
What were Satellos Bioscience earnings last quarter?▼
MSLE earnings for the last quarter are -0.55 USD per share, whereas the estimation was -0.51 USD resulting in a -7.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Satellos Bioscience revenue for the last year?▼
Satellos Bioscience revenue for the last year amounts to 0 USD.
What is Satellos Bioscience net income for the last year?▼
MSLE net income for the last year is -19.87M USD.
How many employees does Satellos Bioscience have?▼
As of September 06, 2026, the company has 21 employees.
In which sector is Satellos Bioscience located?▼
Satellos Bioscience operates in the Health & Wellness sector.
When did Satellos Bioscience complete a stock split?▼
Satellos Bioscience has not had any recent stock splits.
Where is Satellos Bioscience headquartered?▼
Satellos Bioscience is headquartered in Toronto, Canada.